Identification of a novel effector domain of BIN1 for cancer suppression

Greta L. Lundgaard, Natae E. Daniels, Slovénie Pyndiah, Erica K. Cassimere, Kazi M. Ahmed, Amélie Rodrigue, Daisuke Kihara, Carol B. Post, Daitoku Sakamuro

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Bridging integrator 1 (BIN1) is a nucleocytoplasmic adaptor protein with tumor suppressor properties. The protein interacts with and inhibits the c-MYC transcription factor through the BIN1 MYC-binding domain (MBD). However, in vitro colony formation assays have clearly demonstrated that the MBD is not essential for BIN1-mediated growth arrest. We hypothesized that BIN1 contains a MYC-independent effector domain (MID) for cancer suppression. Because a functionally unique domain frequently contains a distinct structure, the human full-length BIN1 protein was subjected to limited trypsin digestion and the digested peptides were analyzed with Edman sequencing and mass spectrometry. We identified a trypsin-resistant peptide that corresponds to amino acids 146-268 of BIN1. It encompassed part of the BAR region, a putative effector region of BIN1. Computational analysis predicted that the peptide is very likely to exhibit coiled-coil motifs, implying a potential role for this region in sustaining the BIN1 structure and function. Like MBD-deleted BIN1, the trypsin-resistant peptide of BIN1 was predominantly present in the cytoplasm and was sufficient to inhibit cancer growth, regardless of dysregulated c-MYC activity. Our results suggest that the coiled-coil BIN1 BAR peptide encodes a novel BIN1 MID domain, through which BIN1 acts as a MYC-independent cancer suppressor.

Original languageEnglish (US)
Pages (from-to)2992-3001
Number of pages10
JournalJournal of cellular biochemistry
Volume112
Issue number10
DOIs
StatePublished - Oct 1 2011

Fingerprint

Peptides
Trypsin
Neoplasms
Tumor Suppressor Proteins
Proteins
Growth
Mass spectrometry
Tumors
Digestion
Assays
Mass Spectrometry
Cytoplasm
Transcription Factors
Amino Acids

Keywords

  • BIN1
  • c-MYC
  • cancer suppression
  • cytoplasmic localization
  • limited proteolysis

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Lundgaard, G. L., Daniels, N. E., Pyndiah, S., Cassimere, E. K., Ahmed, K. M., Rodrigue, A., ... Sakamuro, D. (2011). Identification of a novel effector domain of BIN1 for cancer suppression. Journal of cellular biochemistry, 112(10), 2992-3001. https://doi.org/10.1002/jcb.23222

Identification of a novel effector domain of BIN1 for cancer suppression. / Lundgaard, Greta L.; Daniels, Natae E.; Pyndiah, Slovénie; Cassimere, Erica K.; Ahmed, Kazi M.; Rodrigue, Amélie; Kihara, Daisuke; Post, Carol B.; Sakamuro, Daitoku.

In: Journal of cellular biochemistry, Vol. 112, No. 10, 01.10.2011, p. 2992-3001.

Research output: Contribution to journalArticle

Lundgaard, GL, Daniels, NE, Pyndiah, S, Cassimere, EK, Ahmed, KM, Rodrigue, A, Kihara, D, Post, CB & Sakamuro, D 2011, 'Identification of a novel effector domain of BIN1 for cancer suppression', Journal of cellular biochemistry, vol. 112, no. 10, pp. 2992-3001. https://doi.org/10.1002/jcb.23222
Lundgaard GL, Daniels NE, Pyndiah S, Cassimere EK, Ahmed KM, Rodrigue A et al. Identification of a novel effector domain of BIN1 for cancer suppression. Journal of cellular biochemistry. 2011 Oct 1;112(10):2992-3001. https://doi.org/10.1002/jcb.23222
Lundgaard, Greta L. ; Daniels, Natae E. ; Pyndiah, Slovénie ; Cassimere, Erica K. ; Ahmed, Kazi M. ; Rodrigue, Amélie ; Kihara, Daisuke ; Post, Carol B. ; Sakamuro, Daitoku. / Identification of a novel effector domain of BIN1 for cancer suppression. In: Journal of cellular biochemistry. 2011 ; Vol. 112, No. 10. pp. 2992-3001.
@article{47528450c63946e69fa9895350f260ea,
title = "Identification of a novel effector domain of BIN1 for cancer suppression",
abstract = "Bridging integrator 1 (BIN1) is a nucleocytoplasmic adaptor protein with tumor suppressor properties. The protein interacts with and inhibits the c-MYC transcription factor through the BIN1 MYC-binding domain (MBD). However, in vitro colony formation assays have clearly demonstrated that the MBD is not essential for BIN1-mediated growth arrest. We hypothesized that BIN1 contains a MYC-independent effector domain (MID) for cancer suppression. Because a functionally unique domain frequently contains a distinct structure, the human full-length BIN1 protein was subjected to limited trypsin digestion and the digested peptides were analyzed with Edman sequencing and mass spectrometry. We identified a trypsin-resistant peptide that corresponds to amino acids 146-268 of BIN1. It encompassed part of the BAR region, a putative effector region of BIN1. Computational analysis predicted that the peptide is very likely to exhibit coiled-coil motifs, implying a potential role for this region in sustaining the BIN1 structure and function. Like MBD-deleted BIN1, the trypsin-resistant peptide of BIN1 was predominantly present in the cytoplasm and was sufficient to inhibit cancer growth, regardless of dysregulated c-MYC activity. Our results suggest that the coiled-coil BIN1 BAR peptide encodes a novel BIN1 MID domain, through which BIN1 acts as a MYC-independent cancer suppressor.",
keywords = "BIN1, c-MYC, cancer suppression, cytoplasmic localization, limited proteolysis",
author = "Lundgaard, {Greta L.} and Daniels, {Natae E.} and Slov{\'e}nie Pyndiah and Cassimere, {Erica K.} and Ahmed, {Kazi M.} and Am{\'e}lie Rodrigue and Daisuke Kihara and Post, {Carol B.} and Daitoku Sakamuro",
year = "2011",
month = "10",
day = "1",
doi = "10.1002/jcb.23222",
language = "English (US)",
volume = "112",
pages = "2992--3001",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - Identification of a novel effector domain of BIN1 for cancer suppression

AU - Lundgaard, Greta L.

AU - Daniels, Natae E.

AU - Pyndiah, Slovénie

AU - Cassimere, Erica K.

AU - Ahmed, Kazi M.

AU - Rodrigue, Amélie

AU - Kihara, Daisuke

AU - Post, Carol B.

AU - Sakamuro, Daitoku

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Bridging integrator 1 (BIN1) is a nucleocytoplasmic adaptor protein with tumor suppressor properties. The protein interacts with and inhibits the c-MYC transcription factor through the BIN1 MYC-binding domain (MBD). However, in vitro colony formation assays have clearly demonstrated that the MBD is not essential for BIN1-mediated growth arrest. We hypothesized that BIN1 contains a MYC-independent effector domain (MID) for cancer suppression. Because a functionally unique domain frequently contains a distinct structure, the human full-length BIN1 protein was subjected to limited trypsin digestion and the digested peptides were analyzed with Edman sequencing and mass spectrometry. We identified a trypsin-resistant peptide that corresponds to amino acids 146-268 of BIN1. It encompassed part of the BAR region, a putative effector region of BIN1. Computational analysis predicted that the peptide is very likely to exhibit coiled-coil motifs, implying a potential role for this region in sustaining the BIN1 structure and function. Like MBD-deleted BIN1, the trypsin-resistant peptide of BIN1 was predominantly present in the cytoplasm and was sufficient to inhibit cancer growth, regardless of dysregulated c-MYC activity. Our results suggest that the coiled-coil BIN1 BAR peptide encodes a novel BIN1 MID domain, through which BIN1 acts as a MYC-independent cancer suppressor.

AB - Bridging integrator 1 (BIN1) is a nucleocytoplasmic adaptor protein with tumor suppressor properties. The protein interacts with and inhibits the c-MYC transcription factor through the BIN1 MYC-binding domain (MBD). However, in vitro colony formation assays have clearly demonstrated that the MBD is not essential for BIN1-mediated growth arrest. We hypothesized that BIN1 contains a MYC-independent effector domain (MID) for cancer suppression. Because a functionally unique domain frequently contains a distinct structure, the human full-length BIN1 protein was subjected to limited trypsin digestion and the digested peptides were analyzed with Edman sequencing and mass spectrometry. We identified a trypsin-resistant peptide that corresponds to amino acids 146-268 of BIN1. It encompassed part of the BAR region, a putative effector region of BIN1. Computational analysis predicted that the peptide is very likely to exhibit coiled-coil motifs, implying a potential role for this region in sustaining the BIN1 structure and function. Like MBD-deleted BIN1, the trypsin-resistant peptide of BIN1 was predominantly present in the cytoplasm and was sufficient to inhibit cancer growth, regardless of dysregulated c-MYC activity. Our results suggest that the coiled-coil BIN1 BAR peptide encodes a novel BIN1 MID domain, through which BIN1 acts as a MYC-independent cancer suppressor.

KW - BIN1

KW - c-MYC

KW - cancer suppression

KW - cytoplasmic localization

KW - limited proteolysis

UR - http://www.scopus.com/inward/record.url?scp=80053201482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053201482&partnerID=8YFLogxK

U2 - 10.1002/jcb.23222

DO - 10.1002/jcb.23222

M3 - Article

VL - 112

SP - 2992

EP - 3001

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 10

ER -